Related Experiment Video
Updated: Jul 1, 2026
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
[Anti-restenosis study on a new drug eluting stent]
Ansha Zhao1, Haiyan Zhang, Nan Huang
1Engineer and Material Science, Southwest Jiaotong University, Chengdu 610031, China.
Abstract:
The objective of this experimental study was to assess the effects of a new kind of drug eluting coronary stent. Fourteen mini-pigs were used; seven normal stainless stents and seven new drug eluting stents were implanted in their normal coronary arteries, respectively. Angiography was performed and followed by pressure-fixation of the coronary arteries for light and electron microscopic examinations at the end of three months after implantation. Repeated angiography showed that all the stented coronary segments were open. With no additional antithrombotic treatment, there was no thrombus formed in the stented coronary segments. Scanning electron microscopy analysis showed the implanted stent surface was covered by endomembrane without thrombus formation. The endothelial cell in the membrane was clear and lined by the direction of blood flow. Histomorphological analysis revealed the neointima in normal stainless stent group was thicker than that in new drug eluting stent group, and the neointima was composed of smooth muscle cell and extracellular matrix. The result of this study shows that this kind of stent could reduce the rate of the re-stenosis and occlusion of PTCA. This stent can be used in clinical trials.
Insights
New drug-eluting coronary stents effectively prevented thrombus formation and reduced neointima in mini-pig arteries. This innovative stent shows promise for reducing restenosis and occlusion in percutaneous coronary interventions.
Area of Science:
- Cardiovascular research
- Biomedical engineering
- Medical device technology
Context:
- Percutaneous coronary intervention (PCI) often involves stent implantation to maintain arterial patency.
- Restenosis and thrombosis remain significant challenges following PCI.
- Drug-eluting stents (DES) aim to mitigate these complications by releasing therapeutic agents.
Purpose:
- To evaluate the efficacy of a novel drug-eluting coronary stent in preventing thrombosis and neointimal hyperplasia.
- To compare the performance of the new DES against traditional stainless steel stents in a preclinical model.
Summary:
- A study in mini-pigs implanted seven new DES and seven stainless steel stents in coronary arteries.
- After three months, angiography confirmed all stented segments remained patent without thrombosis.
- Microscopic analysis revealed reduced neointimal thickness and clear endothelialization with the new DES compared to controls.
Impact:
- The novel drug-eluting stent demonstrated a reduced rate of neointimal hyperplasia and no thrombus formation.
- Findings suggest this DES could significantly decrease restenosis and occlusion rates after PCI.
- The stent is suitable for progression to clinical trials for broader patient application.
